Neurexin dysfunction in neurodevelopmental and neuropsychiatric disorders: a PRIMSA-based systematic review through iPSC and animal models

Neurexin dysfunction in neurodevelopmental and neuropsychiatric disorders: a PRIMSA-based systematic review through iPSC and animal models

BackgroundNeurexins, essential synaptic proteins, are linked to neurodevelopmental and neuropsychiatric disorders like autism spectrum disorder (ASD) and schizophrenia.ObjectiveThrough this systematic review, we aimed to shed light on the relationship between neurexin dysfunction and its implication...

Full description

Bibliographic Details
Main Authors:	Dan Shan, Yuming Song, Yanyi Zhang, Cheong Wong Ho, Wenxin Xia, Zhi Li, Fenfen Ge, Qifeng Ou, Zijie Dai, Zhihao Dai
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-02-01
Series:	Frontiers in Behavioral Neuroscience
Subjects:	animal models human induced pluripotent stem cells disease modeling neurexins neuropsychiatric diseases
Online Access:	https://www.frontiersin.org/articles/10.3389/fnbeh.2024.1297374/full

Similar Items

Emerging evidence implicating a role for neurexins in neurodegenerative and neuropsychiatric disorders
by: Katelyn Cuttler, et al.
Published: (2021-10-01)

Structure, function, and pathology of Neurexin-3
by: Rui Zhang, et al.
Published: (2023-09-01)

Neurexins and their ligands at inhibitory synapses
by: Emma E. Boxer, et al.
Published: (2022-12-01)

Modulation of Trans-Synaptic Neurexin–Neuroligin Interaction in Pathological Pain
by: Huili Li, et al.
Published: (2022-06-01)

Neurexin 3 transmembrane and soluble isoform expression and splicing haplotype are associated with neuron inflammasome and Alzheimer’s disease
by: Akitoyo Hishimoto, et al.
Published: (2019-03-01)

Differential regulation of neurexin at glutamatergic and GABAergic synapses
by: Giulia ePregno, et al.
Published: (2013-04-01)

α-Synuclein Preformed Fibrils Bind to β-Neurexins and Impair β-Neurexin-Mediated Presynaptic Organization
by: Benjamin Feller, et al.
Published: (2023-04-01)

Conditional deletion of neurexins dysregulates neurotransmission from dopamine neurons
by: Charles Ducrot, et al.
Published: (2023-07-01)

Human iPSC-Derived Glia as a Tool for Neuropsychiatric Research and Drug Development
by: Johanna Heider, et al.
Published: (2021-09-01)

Quantification of the trans-synaptic partners neurexin-neuroligin in CSF of neurodegenerative diseases by parallel reaction monitoring mass spectrometry
by: Elena Camporesi, et al.
Published: (2022-01-01)

Advances in neurexin studies and the emerging role of neurexin-2 in autism spectrum disorder
by: Sheraz Khoja, et al.
Published: (2023-02-01)

Aerobic Exercise Induces Alternative Splicing of Neurexins in Frontal Cortex
by: Elisa Innocenzi, et al.
Published: (2021-05-01)

Involvement of an Aberrant Vascular System in Neurodevelopmental, Neuropsychiatric, and Neuro-Degenerative Diseases
by: Keiichi Ishihara, et al.
Published: (2023-01-01)

Neurexins in serotonergic neurons regulate neuronal survival, serotonin transmission, and complex mouse behaviors
by: Amy Cheung, et al.
Published: (2023-01-01)

The Perils of Navigating Activity-Dependent Alternative Splicing of Neurexins
by: Kif Liakath-Ali, et al.
Published: (2021-03-01)

NRXN1α+/- is associated with increased excitability in ASD iPSC-derived neurons
by: Sahar Avazzadeh, et al.
Published: (2021-09-01)

Distinct neurexin-cerebellin complexes control AMPA- and NMDA-receptor responses in a circuit-dependent manner
by: Jinye Dai, et al.
Published: (2022-10-01)

Generation and Characterization of a Human-Derived and Induced Pluripotent Stem Cell (iPSC) Line from an Alzheimer’s Disease Patient with Neuropsychiatric Symptoms
by: Ram Sagar, et al.
Published: (2023-12-01)

Balance within the neurexin trans-synaptic connexus stabilises pre-behavioural control
by: Raymond Allan Clarke, et al.
Published: (2014-02-01)

Neurexin and Neuroligins Maintain the Balance of Ghost and Satellite Boutons at the Drosophila Neuromuscular Junction
by: Gan Guangming, et al.
Published: (2020-06-01)

Editorial: Metabolic traits associated with neurodevelopmental and neuropsychiatric disorders
by: Rekha Jagadapillai, et al.
Published: (2023-11-01)

Neurexophilin4 is a selectively expressed α-neurexin ligand that modulates specific cerebellar synapses and motor functions
by: Xiangling Meng, et al.
Published: (2019-09-01)

Neurexin and neuroligins jointly regulate synaptic degeneration at the Drosophila neuromuscular junction based on TEM studies
by: Gan Guangming, et al.
Published: (2023-11-01)

Utilizing hiPSC-derived oligodendrocytes to study myelin pathophysiology in neuropsychiatric and neurodegenerative disorders.
by: Gina Shim, et al.
Published: (2024-01-01)

Computational Saturation Mutagenesis to Investigate the Effects of Neurexin-1 Mutations on AlphaFold Structure
by: Raina Rhoades, et al.
Published: (2022-04-01)

Oligodendroglial Heterogeneity in Neuropsychiatric Disease
by: Sunniva M. K. Bøstrand, et al.
Published: (2021-02-01)

Mild Amnestic Cognitive Impairment and Depressive Symptoms in Autoimmune Encephalitis Associated with Serum Anti-Neurexin-3α Autoantibodies
by: Niels Hansen, et al.
Published: (2021-05-01)

The Unfolded Protein Response and Autophagy as Drug Targets in Neuropsychiatric Disorders
by: Vignesh Srinivasan, et al.
Published: (2020-09-01)

ULK4 in Neurodevelopmental and Neuropsychiatric Disorders
by: Shilin Luo, et al.
Published: (2022-04-01)

Advances in the role of the GADD45 family in neurodevelopmental, neurodegenerative, and neuropsychiatric disorders
by: Mengbing Huang, et al.
Published: (2024-01-01)

Auditory brainstem responses are resistant to pharmacological modulation in Sprague Dawley wild-type and Neurexin1α knockout rats
by: Samuel Marashli, et al.
Published: (2024-03-01)

Proteomics analysis of the p.G849D variant in neurexin 2 alpha may reveal insight into Parkinson’s disease pathobiology
by: Katelyn Cuttler, et al.
Published: (2022-11-01)

Modeling Neurodevelopmental and Neuropsychiatric Diseases with Astrocytes Derived from Human-Induced Pluripotent Stem Cells
by: Baiyan Ren, et al.
Published: (2021-02-01)

Neuropsychiatric symptoms in untreated Parkinson’s disease
by: Szatmari S, et al.
Published: (2017-03-01)

The challenge of neuropsychiatric manifestations in parkinson’s disease. A case report
by: A. Cerame Del Campo, et al.
Published: (2021-04-01)

Neuropsychiatric Aspects of Huntington’s Disease
by: Özlem Devrim Balaban, et al.
Published: (2022-03-01)

Case report: Anti-neurexin-3α-associated autoimmune encephalitis secondary to contrast-induced encephalopathy
by: Lin Zhu, et al.
Published: (2023-03-01)

Neuropsychiatric manifestation of celiac disease: A case-control study in North India
by: Mahendra Nimel, et al.
Published: (2016-01-01)

Neuropsychiatric and Cognitive Sequelae of COVID-19
by: Sanjay Kumar, et al.
Published: (2021-03-01)

Neuropsychiatric disorders correction in Alzheimer's disease
by: N. N. Koberskaya
Published: (2022-06-01)